Inventor · disambiguated record
Winston Zapanta Ong
Also filed as: ONG WINSTON · ONG WINSTON Z · ONG WINSTON ZAPANTA
47 granted patents·12 pending applications·94 citations·filing 2008–2022
97Inventor score
Top patents by PatentIndex Score
59 records- 0195US9458169B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·22 cites·23 claims
- 0294US9790232B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Oct 17, 2017·12 cites·20 claims
- 0393US9353122B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·14 cites·50 claims
- 0491US10160765B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Dec 25, 2018·7 cites·15 claims
- 0590US10618906B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·2 cites·14 claims
- 0687US9877970B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·4 cites·26 claims
- 0787US9580421B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Feb 28, 2017·4 cites·20 claims
- 0886US10398703B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Sep 3, 2019·3 cites·26 claims
- 0985US10758539B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Sep 1, 2020·1 cites·23 claims
- 1085US10336767B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·3 cites·8 claims
- 1184US11104685B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Aug 31, 2021·1 cites·6 claims
- 1283US10626121B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Apr 21, 2020·1 cites·8 claims
- 1383US9861634B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 9, 2018·2 cites·21 claims
- 1483US9353123B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·3 cites·35 claims
- 1582US9827248B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·2 cites·21 claims
- 1682US9688688B2Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·2 cites·16 claims
- 1782US9212145B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Dec 15, 2015·3 cites·80 claims
- 1881US10392388B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 27, 2019·2 cites·38 claims
- 1981US2023116686A1Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2080US9988386B2Compounds for treatment of diseases of abnormal angiogenesis or aberrant growth factors and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jun 5, 2018·3 cites·23 claims
- 2179US10059693B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·29 claims
- 2279US10059692B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·31 claims
- 2378US9802922B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Oct 31, 2017·1 cites·12 claims
- 2476US11713323B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Granted Aug 1, 2023·0 cites·10 claims
- 2575US2021355136A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2674US11369611B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·0 cites·9 claims
- 2774US11352343B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 7, 2022·0 cites·21 claims
- 2874US11091487B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·22 claims
- 2974US2022106326A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3074US2021393641A1Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3173US10975090B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Apr 13, 2021·0 cites·12 claims
- 3272US10966987B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·0 cites·21 claims
- 3372US2021380588A1Novel Compounds and Uses ThereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3471US10723719B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·20 claims
- 3571US2021332048A1Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3670US11021487B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Jun 1, 2021·0 cites·17 claims
- 3769US10954244B2Compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Mar 23, 2021·0 cites·20 claims
- 3868US10766907B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·0 cites·19 claims
- 3968US10329280B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·20 claims
- 4068US10316022B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·18 claims
- 4168US10285991B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted May 14, 2019·0 cites·26 claims
- 4268US10253036B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Apr 9, 2019·0 cites·7 claims
- 4368US2021261562A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4467US10875857B21-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Dec 29, 2020·0 cites·15 claims
- 4567US10351570B2Compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jul 16, 2019·0 cites·25 claims
- 4667US2021087192A11-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses ThereofKALA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4763US10544151B2Compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·0 cites·46 claims
- 4863US9833453B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Dec 5, 2017·0 cites·25 claims
- 4962US10392399B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 27, 2019·0 cites·7 claims
- 5062US9725451B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·0 cites·67 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Winston Zapanta Ong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →